Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 4 Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Depression 2 Vulvar Neoplasms 1 Vomiting 1 Stomach Neoplasms 1 Patient Compliance 1 Pancreatic Neoplasms 1 Non-resectable Metastatic Cancer of the Lung 1 Neuroblastoma 1 Nausea 1 Leukemia 1 Laryngeal Diseases 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Anxiety Disorders 1 Anus Neoplasms 1

Interventions

Cyclophosphamide 6 Isotretinoin 5 thymoglobulin 4 fludarabine phosphate 4 fludarabine 4 aldesleukin 4 Topotecan 4 Temozolomide 4 Melphalan 4 Irinotecan 4 Etoposide 4 ribociclib 3 Thiotepa 3 Interleukin-2 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Bone Marrow Transplantation 3 Antilymphocyte Serum 3 temsirolimus 2 omburtamab I-131 2 dinutuximab 2 Vincristine 2 Tretinoin 2 TPI-287 2 Stem Cell Transplantation 2 Rituximab 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neuroblastoma × Interviews as Topic × Clear all

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡